Norway – Medical equipments, pharmaceuticals and personal care products – Q-TOF A LC/MS for St. Olavs Hospital
SYKEHUSINNKJØP HF
Buyer country
Norway
Publication date
Not specified
Biderra sector
Health and medical
Data source
TED open data
Decision signals
First-pass opportunity review
These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.
- Timing signal
- Deadline not indexed
- Indexed data completeness
- 71%
- Official title coverage
- 7 languages
- Classification signal
- 33000000
Check the official notice
Based on seven decision fields
Preserved from source-supplied versions
Medical equipment, pharmaceuticals and personal care products
Official title versions
TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.
Noruega – Equipamiento y artículos médicos, farmacéuticos y de higiene personal – Q-TOF A LC/MS for St. Olavs Hospital
Noorwegen – Medische apparatuur, farmaceutische artikelen en artikelen voor lichaamsverzorging – Q-TOF A LC/MS for St. Olavs Hospital
Norwegia – Urządzenia medyczne, farmaceutyki i produkty do pielęgnacji ciała – Q-TOF A LC/MS for St. Olavs Hospital
Norvège – Matériels médicaux, pharmaceutiques et produits de soins personnnels – Q-TOF A LC/MS for St. Olavs Hospital
Norwegen – Medizinische Ausrüstungen, Arzneimittel und Körperpflegeprodukte – Q-TOF A LC/MS for St. Olavs Hospital
Norvegia – Apparecchiature mediche, prodotti farmaceutici e per la cura personale – Q-TOF A LC/MS for St. Olavs Hospital
Norway – Medical equipments, pharmaceuticals and personal care products – Q-TOF A LC/MS for St. Olavs Hospital
What Biderra adds
For notice 567846-2026, Biderra has normalized the contracting authority country as Norway, grouped CPV 33000000 under health and medical, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.